| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2014↕ | FY 2013↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.8B | $0.9B | $1.2B | $1.1B | $1.8B | $0.4B | $0.4B |
| Cost of Revenue | $0.3B | $0.3B | $0.3B | $0.4B | $0.4B | — | $0.6B | $0.5B |
| Gross Profit | $0.5B | $0.5B | $0.6B | $0.8B | $0.7B | — | — | — |
| R&D Expense | $0.0B | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $-0.0B | $-0.2B | $0.1B | $0.2B | $0.2B | $-0.0B | $-0.6B |
| Net Income | $0.0B | $-0.1B | $-0.3B | $0.1B | $0.1B | $0.1B | $-0.1B | $-0.6B |
| EPS (Basic) | $0.01 | $-2.00 | $-7.47 | $1.58 | $3.02 | $4.73 | — | — |
| EPS (Diluted) | $0.01 | $-2.00 | $-7.47 | $1.49 | $2.78 | $4.42 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2014↕ | FY 2013↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0.7B | $0.7B | $0.8B | $1.2B | $1.3B | $1.2B | $1.7B | $2.5B |
| Current Assets | $0.2B | $0.2B | $0.3B | $0.4B | $0.4B | $0.4B | $0.5B | $0.6B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.2B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.2B | $0.2B | $0.3B | $0.3B | $0.3B | $0.2B | $0.4B | $0.5B |
| Stockholders' Equity | $0.2B | $0.2B | $0.2B | $0.4B | $0.3B | $0.2B | $-1.1B | $-0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2014↕ | FY 2013↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.0B | $-0.1B | $-0.0B | $-0.1B | $-0.2B | $-0.0B | $-0.0B | $0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.0B | $0.0B | $-0.1B | $-0.1B | $0.0B | $-0.2B | $-0.4B | $-0.5B |